Parry M E, Sharpe G R
Dermatology Unit, Department of Medicine, University of Liverpool, Liverpool L69 3GA, U.K.
Br J Dermatol. 1998 Aug;139(2):254-63. doi: 10.1046/j.1365-2133.1998.02362.x.
The immune response of patients with seborrhoeic dermatitis and healthy age- and sex-matched controls was examined to test the hypothesis that an inadequate or inappropriate immune response to Malassezia yeast leads to seborrhoeic dermatitis. Antibody responses were examined using enzyme-linked immunosorbent assays (ELISAs) and Western blots and lymphocyte responses using lymphocyte proliferation assays. The level of IgG and IgM specific for whole yeast cells or extracted proteins of two isolates of M. furfur was tested in ELISA. A wide range of antibody levels was found but the patient and control groups were indistinguishable (n = 19), and the groups could not be distinguished by the pattern of Malassezia proteins recognized by their sera in Western blots. The average affinity of the subjects' antibodies specific for Malassezia cells or proteins was measured using ammonium thiocyanate dissociation. Most of the sera had moderate affinities corresponding to 50% dissociation at thiocyanate concentrations of 0.5-1.0 mol/L. There was no difference between patients and matched controls. The proliferation of the patients' lymphocytes in response to a number of M. furfur cell preparations was measured: whole cells, cytoplasmic proteins, cell walls, soluble molecules extracted from the cell walls using sonication, and a commercial preparation. There was a wide range of responses between individuals, but there was no difference between the three groups: patients with seborrhoeic dermatitis (n = 16), healthy controls (n = 16) and a group suffering from other inflammatory skin conditions (n = 15). The results do not support the hypothesis that an inadequate immune response to Malassezia yeast could lead to seborrhoeic dermatitis. Other possible pathological mechanisms include toxin production or lipase activity.
对脂溢性皮炎患者以及年龄和性别匹配的健康对照者的免疫反应进行了检测,以验证对马拉色菌酵母的免疫反应不足或不适当会导致脂溢性皮炎这一假设。使用酶联免疫吸附测定(ELISA)和蛋白质印迹法检测抗体反应,使用淋巴细胞增殖测定法检测淋巴细胞反应。在ELISA中检测了针对两株糠秕马拉色菌全酵母细胞或提取蛋白的IgG和IgM水平。发现抗体水平范围广泛,但患者组和对照组无明显差异(n = 19),且通过蛋白质印迹法检测其血清识别的马拉色菌蛋白模式也无法区分两组。使用硫氰酸铵解离法测量了受试者针对马拉色菌细胞或蛋白的抗体的平均亲和力。大多数血清具有中等亲和力,对应于硫氰酸盐浓度为0.5 - 1.0 mol/L时50%的解离。患者与匹配的对照组之间没有差异。测量了患者淋巴细胞对多种糠秕马拉色菌细胞制剂的增殖反应:全细胞、细胞质蛋白、细胞壁、通过超声处理从细胞壁提取的可溶性分子以及一种商业制剂。个体之间的反应范围广泛,但三组之间没有差异:脂溢性皮炎患者(n = 16)、健康对照者(n = 16)和患有其他炎症性皮肤病的一组(n = 15)。结果不支持对马拉色菌酵母免疫反应不足会导致脂溢性皮炎这一假设。其他可能的病理机制包括毒素产生或脂肪酶活性。